# Peptide Peptalk — Cognitive & Nootropic Research Peptides > Peptide Peptalk is an independent reference desk for Cognitive & Nootropic research peptides — Semax and Selank — summarized from peer-reviewed literature. A digest, not a vendor or clinic. A calm, citation-first reading desk for the published science on Semax and Selank — what each was actually studied for, in which species, and how the evidence stacks up in the focus, clarity & cognitive-performance research literature. ## The short version Peptide Peptalk is a reading desk, not a store. It collects what the published research literature actually says about two peptides that come up repeatedly in conversations about **focus, clarity, and cognitive performance**: Semax and Selank. A *peptide* is a short chain of amino acids — the same building blocks that proteins are made from, only much smaller. Each of these two was designed by Russian researchers to nudge something specific in the brain: Semax targets the growth of neurotrophic support proteins (BDNF and NGF) and seems to sharpen attention and protect against ischemic injury in animal models; Selank quiets anxiety-related signaling without the heaviness of a sedative, which in practice can look like focus too — just a different route to get there. This desk does one job: it tells you, in plain language and with citations, what each peptide was actually tested on, in which species (mainly rats and mice), and how far that evidence really reaches. Neither compound is an approved drug in the US or EU. We do not sell anything, we do not give medical advice, and we never list a human dose. ## What are research peptides? Proteins in the body — a receptor in a neuron, a signaling hormone, a structural scaffold — are long chains of amino acids folded into three-dimensional shapes. A *peptide* is a far shorter version of the same thing, sometimes only four to ten amino acids long. Because they are small and chemically specific, peptides can act like keys for particular cellular locks: binding a receptor, switching a gene on or off, modulating an enzyme. A *research peptide* is one that has been synthesized and studied in the laboratory — in cell cultures, in rodents, occasionally in early human pilots — but has **not** been approved by a regulatory body as a medicine. Semax and Selank exist in exactly that space: they are prescription drugs in Russia (the country where they were developed), but everywhere else they are unscheduled research chemicals with no formally validated human dosing, no large controlled trials, and no independent Western regulatory approval. When this site reports a study number, it reports it the way the study did — *studied at 50 micrograms per kilogram in male Wistar rats* — never as a recommendation for humans. ## Focus, clarity & cognitive-performance research — how these two fit Semax and Selank approach the cognitive-performance question from very different angles, which is why they sit on the same desk rather than the same shelf. - [**Semax**](/semax) is the lead. It is a synthetic heptapeptide that started as a fragment of the adrenocorticotropic hormone (ACTH) and was redesigned to upregulate BDNF and NGF — the neurotrophins that support neuron survival, learning, and plasticity [3][4]. In rodent models, a single intranasal dose produced rapid, region-specific changes in neurotrophin gene expression across the hippocampus, brainstem, and frontal cortex. It is also the more active of the two as a nootropic in community reports, with a faster-onset clarity effect that users contrast sharply with stimulants. - [**Selank**](/selank) approaches the same space from the anxiety side. It is a synthetic analog of the immune peptide tuftsin, extended to resist enzymatic breakdown, and its primary characterized mechanism is positive allosteric modulation of GABA receptors combined with inhibition of enkephalin-degrading enzymes [8][10]. When background anxiety quiets, cognitive performance often improves as a secondary consequence — a mechanism Selank's study history captures in ways that differ categorically from Semax. The two are **strictly distinct compounds** — different sequences, different mechanisms, different primary research endpoints — and this desk keeps that distinction sharp. Use the directory to read each one in depth, or [compare these peptides](/compare) side by side. ## How this desk reads the literature Peptide Peptalk is a cross-referenced literature digest. Each compound page summarizes the peer-reviewed studies for that peptide, cites them by number, and links to a single shared [references list](/references) that aggregates every source across both. Where the evidence is preclinical, single-lab, or Russian-origin with no Western replication, we say so plainly — that context is part of the record, not a caveat buried in fine print. We also compile what the broader research community and self-experimenter communities report *anecdotally*, clearly labeled as such, because that layer of signal is real and worth reading honestly even when it does not meet an evidentiary bar. We describe findings; we do not recommend, prescribe, or sell. --- Peptide Peptalk is an independent literature digest — every claim is citation-attributed, every anecdote is labeled, and no compound on this desk is for sale.